Suppr超能文献

抗疟铁喹啉:从实验室到临床。

The antimalarial ferroquine: from bench to clinic.

机构信息

Unité de Catalyse et Chimie du Solide, CNRS UMR 8181, Université Lille Nord de France.

出版信息

Parasite. 2011 Aug;18(3):207-14. doi: 10.1051/parasite/2011183207.

Abstract

Ferroquine (FQ, SSR97193) is currently the most advanced organo-metallic drug candidate and about to complete phase II clinical trials as a treatment for uncomplicated malaria. This ferrocene-containing compound is active against both chloroquine-susceptible and chloroquine-resistant Plasmodium falciparum and P. vivax strains and/or isolates. This article focuses on the discovery of FQ, its antimalarial activity, the hypothesis of its mode of action, the current absence of resistance in vitro and recent clinical trials.

摘要

铁喹(FQ,SSR97193)是目前最先进的有机金属药物候选物,即将完成 II 期临床试验,作为治疗无并发症疟疾的药物。这种含二茂铁的化合物对氯喹敏感和氯喹耐药的恶性疟原虫和间日疟原虫株和/或分离株均有活性。本文重点介绍了 FQ 的发现、抗疟活性、作用机制假说、目前体外无耐药性以及最近的临床试验。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9d5/3671469/3908d70deefa/parasite-18-207-fig1.jpg

相似文献

1
The antimalarial ferroquine: from bench to clinic.
Parasite. 2011 Aug;18(3):207-14. doi: 10.1051/parasite/2011183207.
2
Ex vivo drug susceptibility of ferroquine against chloroquine-resistant isolates of Plasmodium falciparum and P. vivax.
Antimicrob Agents Chemother. 2011 Sep;55(9):4461-4. doi: 10.1128/AAC.01375-10. Epub 2011 Jul 5.
3
Plasmodium vivax susceptibility to ferroquine.
Antimicrob Agents Chemother. 2010 May;54(5):2228-30. doi: 10.1128/AAC.01572-09. Epub 2010 Mar 22.
5
Ferrocene-Based Compounds with Antimalaria/Anticancer Activity.
Molecules. 2019 Oct 7;24(19):3604. doi: 10.3390/molecules24193604.
6
4-Aminoquinoline-ferrocene Hybrids as Potential Antimalarials.
Recent Pat Antiinfect Drug Discov. 2020;15(2):157-172. doi: 10.2174/1574891X15666200804160322.
9
Ferroquine, an ingenious antimalarial drug: thoughts on the mechanism of action.
Molecules. 2008 Nov 20;13(11):2900-7. doi: 10.3390/molecules13112900.

引用本文的文献

1
Ferrocenyl Quinoline-Benzimidazole Hybrids: A Multistage Strategy to Combat Drug-Resistant Malaria.
Inorg Chem. 2025 Aug 11;64(31):16152-16167. doi: 10.1021/acs.inorgchem.5c02689. Epub 2025 Jul 31.
2
Evaluation of Au(III) complexes as Plasmodium falciparum aquaglyceroporin (PfAQP) inhibitors by in silico and in vitro methods.
J Biol Inorg Chem. 2024 Dec;29(7-8):821-836. doi: 10.1007/s00775-024-02081-x. Epub 2024 Nov 23.
3
Recent advances, challenges and updates on the development of therapeutics for malaria.
EXCLI J. 2024 May 6;23:672-713. doi: 10.17179/excli2023-6856. eCollection 2024.
4
Discovery of New Broad-Spectrum Anti-Infectives for Eukaryotic Pathogens Using Bioorganometallic Chemistry.
J Med Chem. 2023 Dec 14;66(23):15867-15882. doi: 10.1021/acs.jmedchem.3c01333. Epub 2023 Nov 27.
5
Steroids Bearing Heteroatom as Potential Drugs for Medicine.
Biomedicines. 2023 Oct 3;11(10):2698. doi: 10.3390/biomedicines11102698.
6
Investigation of new ferrocenyl-artesunate derivatives as antiparasitics.
Dalton Trans. 2023 Nov 7;52(43):15786-15797. doi: 10.1039/d3dt02254d.
8
Fighting Plasmodium chloroquine resistance with acetylenic chloroquine analogues.
Int J Parasitol Drugs Drug Resist. 2022 Dec;20:121-128. doi: 10.1016/j.ijpddr.2022.10.003. Epub 2022 Oct 31.

本文引用的文献

1
The antimalarial ferroquine: role of the metal and intramolecular hydrogen bond in activity and resistance.
ACS Chem Biol. 2011 Mar 18;6(3):275-87. doi: 10.1021/cb100322v. Epub 2011 Jan 7.
2
Organometallic complexes: new tools for chemotherapy.
Curr Med Chem. 2010;17(25):2729-45. doi: 10.2174/092986710791859306.
3
Plasmodium vivax susceptibility to ferroquine.
Antimicrob Agents Chemother. 2010 May;54(5):2228-30. doi: 10.1128/AAC.01572-09. Epub 2010 Mar 22.
4
Artemisinin resistance: current status and scenarios for containment.
Nat Rev Microbiol. 2010 Apr;8(4):272-80. doi: 10.1038/nrmicro2331. Epub 2010 Mar 8.
5
Antimalarial drug development: past to present scenario.
Mini Rev Med Chem. 2009 Oct;9(12):1447-69. doi: 10.2174/138955709789957323.
7
Resistance to therapies for infection by Plasmodium vivax.
Clin Microbiol Rev. 2009 Jul;22(3):508-34. doi: 10.1128/CMR.00008-09.
8
The global portfolio of new antimalarial medicines under development.
Clin Pharmacol Ther. 2009 Jun;85(6):584-95. doi: 10.1038/clpt.2009.51. Epub 2009 Apr 29.
9
The pathophysiology of vivax malaria.
Trends Parasitol. 2009 May;25(5):220-7. doi: 10.1016/j.pt.2009.02.003. Epub 2009 Apr 6.
10
The persistent problem of malaria: addressing the fundamental causes of a global killer.
Soc Sci Med. 2008 Sep;67(5):854-62. doi: 10.1016/j.socscimed.2008.05.013. Epub 2008 Jun 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验